Gastric lavage with paraffin oil for aluminum phosphide poisoning
Official title: Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning: A Randomized Controlled Clinical Trial
Run by Tanta University · NCT04499885 · Data updated 2026-11-12
This study tests if using paraffin oil for stomach washing can help people who have been poisoned by aluminum phosphide recover better than using regular saline or sodium bicarbonate.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 62 (estimated) |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta) |
| Status | Recruiting |
| Started | June 1, 2020 |
| Main results expected | December 1, 2030 |
| Study ends | December 10, 2030 |
| Registry record updated | August 5, 2020 |
| Trial ID | NCT04499885 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are symptomatic patients who have experienced acute aluminum phosphide poisoning.
✕Probably not a fit
Patients who may not benefit include those who are asymptomatic, have ingested other substances, or have significant pre-existing medical conditions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of gastric lavage using paraffin oil in patients suffering from acute aluminum phosphide poisoning. It is a randomized controlled clinical trial comparing the outcomes of paraffin oil gastric lavage against traditional saline and sodium bicarbonate lavage. The goal is to determine if paraffin oil can improve patient recovery and reduce toxicity from aluminum phosphide exposure. The trial will include symptomatic patients who meet specific inclusion criteria while excluding those with certain medical conditions or previous interventions.
Why it matters
Potential benefit: If successful, this approach could provide a more effective treatment option for patients suffering from acute aluminum phosphide poisoning.
How similar studies have gone: There is limited information on the success of similar approaches, making this study a potentially novel investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Patients with symptomatic acute aluminum phosphide poisoning Exclusion Criteria: * • Pregnant and lactating women * Asymptomatic patients with history of acute aluminum phosphide exposure. * Patients with ingestion or exposure to other substances in addition to aluminum phosphide. * Patients with other major medical conditions (e.g. cardiovascular disease, renal or hepatic failure). * Patients with previous medical intervention (had gastric lavage in any medical center before admission). * Patients with disturbed consciousness level * Patients with post cardiac arrest cases
Where it's running
-
Sherief Abd-Elsalam
Tanta, Egypt Recruiting
Study contacts
- Principal investigator: Nadia Ezzat Helal, Ass. Prof. — Forensic medicine Department- Tanta University
- Study coordinator: Sherief Abd-Elsalam, ass. prof.
- Email: sheriefabdelsalam@yahoo.com
- Phone: 00201147773440
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Stopping nivolumab early for melanoma treatment
This study is testing if stopping nivolumab early is safe and effective for patients with advanced melanoma who have responded well to their initial treatment.
-
Observing genetic factors in Indian children with leukemia
This study looks at how genetic differences might affect side effects from chemotherapy in Indian children with leukemia to see how it impacts their quality of life.
-
Monitoring drug levels to improve outcomes in metastatic kidney cancer patients
This study is testing how monitoring drug levels and certain genetic factors can help improve treatment outcomes for people with metastatic kidney cancer.
-
Improving drug adherence in cancer patients through a multidisciplinary consultation program
This study tests whether a special consultation program can help cancer patients stick to their oral medication plans better by addressing their challenges.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.